{
  "meta": {
    "data_length": 1,
    "message": "Proposition id 252 retrieved successfully",
    "request_url": "http://api.moalmanac.org/propositions?proposition_id=252",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.017219,
    "timestamp_received": "2026-06-08T13:58:49.554214+00:00Z",
    "timestamp_returned": "2026-06-08T13:58:49.571433+00:00Z",
    "trace_id": "ca8bed2f-aa06-4553-8690-af8cd02549a6"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-05-07"
  },
  "data": [
    {
      "id": 252,
      "type": "VariantTherapeuticResponseProposition",
      "predicate": "predictSensitivityTo",
      "biomarkers": [
        {
          "id": 51,
          "name": "HRD",
          "genes": [],
          "type": "CategoricalVariant",
          "extensions": [
            {
              "name": "biomarker_type",
              "value": "Homologous Recombination"
            },
            {
              "name": "present",
              "value": true
            },
            {
              "name": "status",
              "value": "Deficient"
            }
          ]
        }
      ],
      "subjectVariant": {},
      "conditionQualifier": {
        "id": 27,
        "conceptType": "Disease",
        "name": "High-Grade Serous Fallopian Tube Cancer",
        "primaryCoding": {
          "id": "oncotree:HGSFT",
          "code": "HGSFT",
          "name": "High-Grade Serous Fallopian Tube Cancer",
          "system": "https://oncotree.mskcc.org",
          "systemVersion": "oncotree_2021_11_02",
          "iris": [
            "https://oncotree.mskcc.org/?version=oncotree_2021_11_02&field=CODE&search=HGSFT"
          ]
        },
        "mappings": []
      },
      "objectTherapeutic": {
        "id": 43,
        "membership_operator": "AND",
        "therapies": [
          {
            "id": 46,
            "conceptType": "Drug",
            "name": "Olaparib",
            "primaryCoding": {
              "id": "ncit:C71721",
              "code": "C71721",
              "name": "Olaparib",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C71721"
              ]
            },
            "mappings": [
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "rxcui:1597582",
                  "code": "1597582",
                  "name": "olaparib",
                  "system": "RxNorm",
                  "systemVersion": "02-Mar-2026",
                  "iris": [
                    "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1597582"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:45892579",
                  "code": "45892579",
                  "name": "olaparib",
                  "system": "OMOP",
                  "systemVersion": "v20260227",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/45892579"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "sctid:432162002",
                  "code": "432162002",
                  "name": "Olaparib",
                  "system": "SNOMED",
                  "systemVersion": "2025-03-01",
                  "iris": [
                    "https://browser.ihtsdotools.org/?perspective=full&conceptId1=432162002&edition=MAIN/2025-03-01&release=&languages=en"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:4332351",
                  "code": "4332351",
                  "name": "Olaparib",
                  "system": "OMOP",
                  "systemVersion": "v20260227",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/4332351"
                  ]
                }
              }
            ],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "PARP inhibition"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Targeted therapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          },
          {
            "id": 11,
            "conceptType": "Drug",
            "name": "Bevacizumab",
            "primaryCoding": {
              "id": "ncit:C2039",
              "code": "C2039",
              "name": "Bevacizumab",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2039"
              ]
            },
            "mappings": [
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "rxcui:253337",
                  "code": "253337",
                  "name": "bevacizumab",
                  "system": "RxNorm",
                  "systemVersion": "20250602",
                  "iris": [
                    "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=253337"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:4247981",
                  "code": "4247981",
                  "name": "Bevacizumab",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/4247981"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "sctid:409406007",
                  "code": "409406007",
                  "name": "Bevacizumab",
                  "system": "SNOMED",
                  "systemVersion": "2026-03-01",
                  "iris": [
                    "https://browser.ihtsdotools.org/?perspective=full&conceptId1=409406007&edition=MAIN/2026-03-01&release=&languages=en"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:1397141",
                  "code": "1397141",
                  "name": "bevacizumab",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/1397141"
                  ]
                }
              }
            ],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "VEGF inhibition"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Targeted therapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          }
        ]
      }
    }
  ]
}